Pediatric hydrocephalus outcomes: a review

Matthieu Vinchon1, Harold Rekate, Abhaya V Kulkarni

  • 1Department of Pediatric Neurosurgery, Lille University Hospital, Lille, France. matthieu.vinchon@chru-lille.fr.

Insights

Pediatric hydrocephalus outcomes vary widely, with significant long-term challenges in shunt survival, neurological sequelae, and social integration. More research is needed to understand these complex outcomes and improve patient care.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Developmental Pediatrics

Background:

  • Pediatric hydrocephalus management involves complex treatments with uncertain long-term outcomes.
  • Significant gaps exist in understanding very long-term social and clinical sequelae, and factors influencing outcomes.

Purpose of the Study:

  • To review and synthesize current knowledge on pediatric hydrocephalus outcomes.
  • To highlight disparities in reported outcomes and identify areas for future research.

Main Methods:

  • Comprehensive review of English-language literature on pediatric hydrocephalus outcomes.
  • Analysis of surgical outcomes (shunt survival, infection), clinical sequelae (neurological, cognitive, epilepsy), and social integration.

Main Results:

  • Mortality rates range from 0-3%. Shunt event-free survival is approximately 70% at 1 year and 40% at 10 years.
  • Cognitive sequelae affect 12-50% of children, school difficulties impact 20-60%, and epilepsy occurs in 6-30% of patients.
  • Long-term social integration data are sparse, with reported poor outcomes in a substantial number of adults.

Conclusions:

  • Wide variations in reported outcomes underscore the need for standardized evaluation methods.
  • Further controlled, prospective studies are crucial to elucidate long-term consequences and guide future research directions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...